Low-Dose Sumatriptan Injection Effective as Acute Migraine Treatment
A phase 3 study examined a low-dose subcutaneous autoinjection of sumatriptan in the acute treatment of migraines with or without aura in adults.
Sumatriptan
DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
DFN-02 nasal spray may be effective, well tolerated, and safe for the acute treatment of episodic migraine.
Novel Nasal Spray for Migraine Attacks to Be FDA-Reviewed
DFN-02 was evaluated in a multicenter, double-blind, randomized, placebo-controlled study (N=107) which showed it was effective in treating pain and associated symptoms during a migraine attack and in reducing attack-related functional disability.
Sumatriptan Needle-Free Injection for Migraine Discontinued
Sumavel DosePro was approved in 2009 for the acute treatment of migraine or cluster headaches as a needle-free delivery system supplied in prefilled pens, and is being discontinued.
Migraine-Associated Nausea Improved With Intranasal Sumatriptan
Nasal sumatriptan powder was associated with more favorable nausea outcomes compared with oral sumatriptan tablets in patients with acute migraine.
Intranasal Sumatriptan Increases Risk for Taste Disturbance
The use of intranasal sumatriptan is an effective treatment for patients with acute migraine attacks; however, future investigations are needed to better understand differences in routes of administration and other therapies for migraine.
Nasal Sumatriptan Results in Faster Migraine Pain Relief
Nasal administration of sumatriptan powder in patients with migraine results in quicker reductions in pain intensity and migraine-related disability compared with oral sumatriptan.
Novel Intranasal Delivery of Sumatriptan May Provide Rapid, Prolonged Migraine Relief
Nasal delivery provides rapid relief
Next post in Migraine & Headache
